Research & Development: Page 47
-
PharmaVoice Team/PharmaVoice
Red Zone: Avoid Enrollment Pitfalls by Engaging with Best-Fit Sites
Perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25 percent of all clinical studies close because they fail to meet enrollment targets.1 For decades, sponsors have found their “best fit" sites and returned to them f...
By WCG Clinical Services • Sept. 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
Medical affairs is in the midst of a transformation. The dynamics of the healthcare industry, the complexity of new science, and the breadth and sophistication of communication channels that physicians have available for accessing information, are expanding the role of medical affairs and reshapi...
By PharmaVoice Team • Sept. 1, 2018 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
For Their Transformative Inspiration and Influence Transformation is easy to define: a thorough or dramatic change in form or appearance. Transformation is much harder to achieve. For this special — and my favorite — issue we asked this year’s PharmaVOICE 100 to provide a short response to the st...
By Taren Grom • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Change Agents
Dr. Patrice Matchaba For Advancing the Quest for Global Access Title: Group Head of Global Health & Corporate Responsibility Company: Novartis AG Education: MD, University of Zimbabwe; Harvard Business School Program for Management Development A number of years ago, Dr. Patrice Matchaba’s mot...
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Clinical Experts
Nariman Nasser For Creating Opportunities for Sites Title: VP, Site Engagement Company: Continuum Clinical Education: BS Microbiology, Arizona State University Hobbies: Swimming, biking, snowboarding, and anything outdoors that provides an adrenaline rush Associations: SoCRA, DIA, ACRP Social Med...
By PharmaVoice Team • Aug. 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Transforming for the Future By definition transformation means a thorough or dramatic change in form or appearance. Our thought leaders in this month’s cover story believe such a reshaping is necessary for the industry to have success in the future as biopharma companies must meet the business ch...
By Taren Grom • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Way to Deliver Proteins Paul Wotton, Ph.D., CEO of Sigilon Therapeutics, discusses his company’s approach for delivering cells that avoid immune detection. Encapsulated cell therapy is an emerging area of biopharmaceutical research that aims to unleash the therapeutic potential of cells to ...
By Paul Wotton • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Sanofi Pasteur’s Approach to Vaccine Deployment Dr. Joël Calmet, Senior Director of Communications at Sanofi-Pasteur, discusses the company’s efforts to bring vaccines to underserved patient populations. PV: Why is patient access to vaccines in disadvantaged countries still a challenge? Calmet: D...
By Dr. Joel Calmet • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Transformation: Is the Industry Ready?
Although the pharma industry scored pretty low on a McKinsey scale of digital maturity, there is evidence that it is moving — perhaps only incrementally — toward a digital transformation that can streamline processes, generate collaboration, and coordinate data collection. The pharma sector, not ...
By PharmaVoice Team • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Regenerative Medicine: The Dawn of a New Age of Biology
Regenerative medicine could completely shake up the way diseases are treated. According to Reportlinker, the regenerative medicine market will reach an estimated $50.55 billion by 2025 thanks to the rapid growth of stem cell and gene therapy in developed markets. Scott Bruder, M.D., Ph.D., founde...
By Kim Ribbink • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Red Zone: Personalized Medicine Requires Personalized Measurement
CNS is the second largest area of pharmaceutical research, but the success rate has been low and approvals rare. In CNS drug development, it is common for investigational therapies to show promising effects in earlier trials, only to fail in the final stages of testing. Some of the reasons can be...
By Sofija Jovic • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
Understanding The Why Applying health psychology to deliver effective patient support As a health and clinical psychologist, I’ve spent the last ten years helping the healthcare industry address the self-management needs of patients living with long-term conditions. For the most part, this work h...
By Kate Perry • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Riding the AI Wave It would be hard to identify a hotter trend right now than artificial intelligence and machine learning — a trend 60 years in the making since John McCarthy coined the term AI while leading a Dartmouth Summer Research Project. Merriam-Webster defines AI as: a branch of computer...
By Taren Grom • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Upfront
Acorda Rallies Parkinson’s Community Acorda Therapeutics has launched the “Live Well. Do Tell." initiative for the Parkinson’s disease community. Its goal is to encourage the community to improve conversations about Parkinson’s symptoms among the circle of care, including people with Parkinson’s,...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Researchers Develop Nanovesicle Method for Tumor Treatment Trend Watch: Technology boosts cancer care. According to a report by Penn State News, a team of scientists working at Penn State University, Second Affiliated Hospital of Southeast University, and Jiangsu Cancer Hospital & Jiangsu Ins...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A Robotic Pill that Creates Oral Biologics Mir Imran, Chairman and CEO of Rani Therapeutics, talks about his company’s efforts to develop an injection-free, large-molecule delivery system. Biologics can only be administered through an injection, which can affect quality of life and patient compli...
By Mir Imran • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Making Sense of Antisense Technology Brett Monia, Ph.D., Chief Operating Officer and Senior VP, Antisense Drug Discovery and Translational Medicine at Ionis Pharmaceuticals, talks about the company’s pipeline of antisense technology products. Antisense technology presents an opportunity to manipu...
By Brett Monia • March 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Blood Test Uses Machine Learning to Detect Multiple Early-Stage Cancers Trend Watch: Digital therapeutics, chips, patches, and machine learning enable better health outcomes. Johns Hopkins Kimmel Cancer Center researchers developed a single blood test — CancerSEEK, a unique noninvasive, multi-ana...
By PharmaVoice Team • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Addressing Diversity in Clinical Trials
Eliminating health disparities is an important public health issue, concerning all stakeholders. In oncology, for example, there are five cancers where disparities in adults have been identified: prostate cancer, breast cancer, colorectal cancer, hepatocellular carcinoma, and multiple myeloma. Fo...
By Denise Myshko • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
From Discovery to Clinical Practice: A Brand Journey Requires Connected Thinking Today’s pharmaceutical brands are on the journey of a lifetime. And throughout this journey a brand takes on a burgeoning number of data sets, from pre-clinical trials all the way to real-world evidence and populat...
By Louisa Holland • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Using Stem Cells to Treat Frailty Longeveron’s Chief Science Officer and Co-Founder Dr. Joshua Hare talks about the company’s cell-based therapies for age-related diseases. Breakthroughs in stem cell research could potentially lead to new treatment options for chronic diseases and injuries affec...
By Dr. Joshua Hare • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Draper R&D Uses Technology to Solve Unmet Healthcare Needs Trend Watch: Health technology is providing quicker, safer solutions for disease management and care. Draper, a nonprofit research and development company focused on advanced technological solutions, has designed the first pediatric h...
By PharmaVoice Team • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Connecting Silos Through System Integration Monica Kennedy, Director of Regulatory Operations at Halozyme, discusses how technology can be leveraged to address inefficiencies in organizations. PV: What do think has led to operational silos and created inefficiencies? Kennedy: Technology is one f...
By Monica Kennedy • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient-Centric Trial Recruitment
Social media, mobile, and other technologies are making patient and physician outreach easier and more cost-effective and analytical tools are enhancing performance measurement, but patient recruitment for clinical trials continues to be a challenge. This is especially true for trials involving r...
By Denise Myshko • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Outsourcing: The Growth and Expansion of Outsourcing
Outsourcing in the pharma industry continues to increase, with many companies spending $50 million or more a year on outsourcing services. A survey from Outsourcing-Pharma.com found that 44% of pharmaceutical companies expected to outsource more business in 2017 than the previous year, and only 1...
By PharmaVoice Team • Feb. 1, 2018
Previous
